Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
Am J Hosp Palliat Care. 2017 Jan 01;:1049909117716460
Authors: Rashid S, Fields AR, Baumrucker SJ
Abstract
Post-thoracotomy pain syndrome (PTPS) is a traumatic neuropathy that can affect as many as 50% of patients undergoing thoracotomy. Patients are often refractory to conservative management and may require multiple analgesics for adequate pain control. Botulinum toxin, derived from Clostridium botulinum, has many uses in treating conditions involving spasticity, dystonia, chronic migraine, and a variety of pain disorders including neuropathies. Botulinum toxin type A injections may provide an alternative or adjunct to improve symptom management in patients with PTPS.
PMID: 28641445 [PubMed - as supplied by publisher]
Source: The American Journal of Hospice and Palliative Care - Category: Palliative Care Authors: Rashid S, Fields AR, Baumrucker SJ Tags: Am J Hosp Palliat Care Source Type: research
More News: Botox | Brain | Chronic Pain | Dystonia | Headache | Migraine | Neurology | Pain | Pain Management | Palliative | Palliative Care | Thoracotomy